Kailen Gonzalez, PA
Medical · Fort Myers, FLNPI 1255607750
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (40.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Coloplast accounts for 89.4% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $24,624, more than ten times the $917 reported in 2021. Among medical clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 191 payments — averaging $150.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$26K
- Procept Biorobotics Corporation$564
- Johnson & Johnson$455
- Endo USA, Inc.$383
- Boston Scientific$357
- Astellas Pharma US Inc$319
- plus $965 from 17 others
What the payments were for
- Consulting fees$11,70141%
- Travel & lodging$6,51523%
- Food & beverage$10,25636%
- Education$3651%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 105 | $25,795 |
| Procept Biorobotics Corporation | 11 | $564 |
| Johnson & Johnson | 18 | $455 |
| Endo USA, Inc. | 7 | $383 |
| Boston Scientific | 6 | $357 |
| Astellas Pharma US Inc | 9 | $319 |
| Endo Pharmaceuticals Inc. | 7 | $229 |
| Innovation Technologies Inc | 1 | $169 |
| AbbVie(2 entities) | 6 | $97 |
| Acerus Pharmaceuticals Corporation | 1 | $76 |
| Tolmar Pharmaceuticals, Inc. | 4 | $75 |
| Antares Pharma, Inc. | 1 | $50 |
| Teleflex LLC | 2 | $38 |
| Urogen Pharma, Inc. | 2 | $38 |
| Pfizer | 2 | $34 |
| Myriad Genetic Laboratories, Inc. | 2 | $33 |
| Organogenesis Inc. | 1 | $24 |
| Axonics, Inc. | 1 | $24 |
| Laborie Medical Technologies Corp. | 1 | $21 |
| Urovant Sciences Inc | 1 | $16 |
| Amgen | 1 | $15 |
| Verity Pharmaceuticals Inc. | 1 | $13 |
| Mission Pharmacal Company | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$23,401
- SPEEDICATH$701
- XIAFLEX$456
- AMS 700$242
- Irrisept$169
- AquaBeam Robotic System$143
- AVEED$122
How this compares
$28,837 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 69 | $43,544 |
| Testosterone | 64 | $9,226 |
| Testosterone Cypionate | 226 | $7,922 |
| Tamsulosin Hcl | 263 | $3,047 |
| Silodosin | 35 | $2,050 |
| Methenamine Hippurate | 26 | $1,933 |
| Pentoxifylline | 53 | $1,122 |
| Finasteride | 40 | $649 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 36 | $494 |
| Oxybutynin Chloride ErOxybutynin Chloride | 18 | $476 |
| Anastrozole | 73 | $327 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $233 |
| Ciprofloxacin Hcl | 17 | $91 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $319 | $43,54469 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,031 medical providers in Florida.
Other medical in Fort Myers
- Demi SouletFort Myers$15K
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.